Core Viewpoint - The article discusses the construction project of a collagen production line by Shandong Furida Biotechnology Co., Ltd., highlighting its investment, production capacity, and timeline for completion [2]. Summary by Sections Project Progress - Shandong Furida Biotechnology Co., Ltd. is expanding its collagen production line, located in Linyi City, Shandong Province, with a total investment of 12 million yuan, including 500,000 yuan for environmental protection [2]. - The project will utilize existing facilities and is expected to produce 200 kg of collagen annually upon completion in June 2025 [2]. Existing Project Status - The company has several ongoing projects, including: - Sodium hyaluronate project with an annual output of 50 tons [4]. - Various fermentation projects with different production capacities, including: - Recombinant Type II collagen: 115.2 kg/a - Recombinant Type XVII collagen: 64 kg/a - Recombinant Type III transmembrane collagen: 20.8 kg/a - The total annual production capacity for collagen will reach 200 kg [3][4]. Industry Events - The fourth Synthetic Biology and Green Bio-Manufacturing Conference (SynBioCon 2025) will be held from August 20-22, 2025, in Ningbo, Zhejiang Province, focusing on AI and bio-manufacturing, green chemicals, new materials, future food, and agriculture [8][9].

Core Viewpoint - The SynBioCon 2025 conference will focus on the integration of AI with biomanufacturing, green chemistry, new materials, future food, and agriculture, aiming to explore the development trends of the biomanufacturing industry during the 14th Five-Year Plan period [1][2]. Group 1: Conference Overview - The conference will take place from August 20-22, 2025, at the Sheraton Hotel in Ningbo, Zhejiang [1]. - It will feature various activities including a youth forum, high-level discussions, and a closed-door seminar on the "2025 AI Empowering Biomanufacturing Industry Innovation Development Blue Book" [1][2]. Group 2: Organizing Institutions - The event is organized by Ningbo Detaizhong Research Information Technology Co., Ltd. (DT New Materials) and supported by several academic and industry institutions, including Peking University Ningbo Institute of Ocean Medicine and Ningbo Enzyme Science Biotechnology Co., Ltd. [2]. Group 3: Agenda Highlights - Day 1 will include registration, a high-level discussion on biomanufacturing, and a youth forum focused on innovation [5][9]. - Day 2 will feature an opening ceremony, macro forums on biomanufacturing, and specialized discussions on green chemistry and new materials [6][12]. - Day 3 will focus on AI applications in biomanufacturing and future food and agriculture discussions [27][30]. Group 4: Key Publications - The conference will announce the "China Synthetic Biology Industry Distribution Map (2025 Edition)" which includes a list of over 500 representative companies in the biomanufacturing sector [33].

Core Viewpoint - The article emphasizes the development of the biomanufacturing industry in Hubei Province, which is seen as a key future industry as outlined in the 2025 government work report, aiming to transform small microorganisms into large-scale industries [1]. Group 1: Agricultural Biomanufacturing - Hubei Fubon Technology Co., Ltd. is focusing on innovative agricultural biopreparations, developing new biodegradable coating agents and soil restoration agents to enhance grain yield [2]. - The company's core product, "biostimulants," acts as a "lubricant" and "amplifier" in agricultural production, improving the efficiency of pesticides and fertilizers [4]. - The research team led by Professor Chen Shouwen from Hubei University has developed a biostimulant using Bacillus licheniformis, showcasing advantages in bioprocessing and broad applications [4]. Group 2: Industrial Microbial Strains - Industrial microbial strains are considered the "chips" of biomanufacturing, with over 80% of core industrial strains in China being dependent on foreign sources [6]. - Research on the strain "Pseudomonas putida" has shown its potential to convert agricultural waste into ethanol, presenting a sustainable alternative to traditional methods that rely on food crops [8]. - Wuhan Ruijia Kang Biotechnology Co., Ltd., founded by Professor Yang Shihui, has developed cellulose ethanol and D-lactic acid, with plans to achieve a production scale of 100,000 tons within five years [8]. Group 3: Collaborative Innovation - Hubei Province is building a collaborative system involving government, industry, academia, and finance to accelerate the development of biomanufacturing [9]. - Hubei University has established partnerships with companies like Angel Yeast to create a joint innovation platform for synthetic biology and modern biomanufacturing [10]. - The provincial government is addressing technology demands across various sectors to promote high-quality development in the synthetic biology industry during the 14th Five-Year Plan [12].

Core Viewpoint - Tianjin Lianlong New Materials Co., Ltd. is a leading company in the polymer materials anti-aging industry, expanding its business beyond polymer additives into three main business lines: polymer materials anti-aging, lubricant additives, and life sciences [2][3]. Business Development - The company has established three business curves: the first curve focuses on polymer materials anti-aging, the second on lubricant additives, and the third on life sciences [2]. - The life sciences business began in 2021 through a partnership with Jima Gene to form Aorife Biopharmaceutical Co., Ltd., focusing on the research, production, and sales of nucleic acid drugs [3]. Research and Collaboration - Lianlong has formed a synthetic biology research institute, led by Chief Scientist Sun Chunguang, with a team from prestigious universities such as Tianjin University and Dalian University of Technology [5][7]. - The company has established partnerships with top universities and research institutes to support early-stage research projects in fine chemical industry [7]. Future Prospects - With ongoing projects and advancements in research, Lianlong is expected to secure a significant position in the synthetic biology field [8].